0001209191-20-020095.txt : 20200318 0001209191-20-020095.hdr.sgml : 20200318 20200318185221 ACCESSION NUMBER: 0001209191-20-020095 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200317 FILED AS OF DATE: 20200318 DATE AS OF CHANGE: 20200318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BREITMEYER JAMES B CENTRAL INDEX KEY: 0001244823 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50549 FILM NUMBER: 20725977 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 434-1113 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: GTX INC /DE/ DATE OF NAME CHANGE: 20030822 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-17 0 0001260990 Oncternal Therapeutics, Inc. ONCT 0001244823 BREITMEYER JAMES B 12230 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer Stock Option 3.33 2020-03-17 4 A 0 66890 0.00 D 2030-03-17 Common Stock 66890 66890 D Fully vested on grant date. /s/ Hazel M. Aker, Attorney-in-fact 2020-03-18